Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹31 Cr₹30 Cr₹40 Cr₹11 Cr₹0.16 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹31 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹31 Cr
Mar2024₹30 Cr
Mar2023₹40 Cr
Mar2022₹11 Cr
Mar2021₹0.16 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹31 Cr
0.51
Mar2024 ₹30 Cr
-23.13
Mar2023 ₹40 Cr
272.42
Mar2022 ₹11 Cr
6,423.93
Mar2021 ₹0.16 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹616.1 Cr -0.8% -7.2% 39.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,594.0 Cr -2.1% -5.8% -6.7% Stock Analytics
DIVIS LABORATORIES ₹162,722.0 Cr 3.1% -6.5% 28.7% Stock Analytics
CIPLA ₹127,508.0 Cr 2.2% 3.2% 1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,111.0 Cr -1.7% NA 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,225.0 Cr 1.4% -1.1% -7.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-0.8%

-7.2%

39.1%

SENSEX

-2.2%

-1.7%

-1.2%


You may also like the below Video Courses